| CAS NO: | 528-58-5 |
| 包装: | 20mg |
| 市场价: | 2310元 |
| Cas No. | 528-58-5 |
| 别名 | 氯化花青素; IdB 1027 |
| 化学名 | 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol;chloride |
| Canonical SMILES | C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)O)O)O)O.[Cl-] |
| 分子式 | C15H11O6Cl |
| 分子量 | 322.7 |
| 溶解度 | ≥ 33.3 mg/mL in DMSO, ≥ 13.04 mg/mL in EtOH, ≥ 10.83 mg/mL in Water with gentle warming |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Cyanidin Chloride (IdB 1027), a subclass of anthocyanin, displays antioxidant and anti-carcinogenesis properties. Cyanidin Chloride (IdB 1027) inhibits osteoclast formation, hydroxyapatite resorption, and receptor activator of NF-κB ligand (RANKL)-induced osteoclast marker gene expression[1]. Cyanidin Chloride (IdB 1027) inhibits receptor activator of NF-κB ligand (RANKL)-induced NF-κB activation, suppresses the degradation of IκB-α and attenuates the phosphorylation of extracellular signal-regulated kinases (ERK). Cyanidin Chloride (IdB 1027) abrogates RANKL-induced calcium oscillations, the activation of nuclear factor of activated T cells calcineurin-dependent 1 (NFATc1), and the expression of c-Fos[1]. Cyanidin Chloride (IdB 1027) protects against OVX-induced bone loss in OVX-induced osteoporosis mouse model[1]. References: |
m.cnreagent.com